- Home
- SGMO vs BANX Comparison
SGMO vs BANX Comparison
Compare SGMO & BANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- BANX
- Stock Information
- Founded
- SGMO 1995
- BANX 2013
- Country
- SGMO United States
- BANX United States
- Employees
- SGMO N/A
- BANX N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- BANX Trusts Except Educational Religious and Charitable
- Sector
- SGMO Health Care
- BANX Finance
- Exchange
- SGMO Nasdaq
- BANX Nasdaq
- Market Cap
- SGMO 122.8M
- BANX 146.9M
- IPO Year
- SGMO 2000
- BANX N/A
- Fundamental
- Price
- SGMO $0.68
- BANX $21.99
- Analyst Decision
- SGMO Strong Buy
- BANX
- Analyst Count
- SGMO 7
- BANX 0
- Target Price
- SGMO $5.29
- BANX N/A
- AVG Volume (30 Days)
- SGMO 5.4M
- BANX 23.4K
- Earning Date
- SGMO 11-11-2025
- BANX 06-17-2025
- Dividend Yield
- SGMO N/A
- BANX 9.66%
- EPS Growth
- SGMO N/A
- BANX N/A
- EPS
- SGMO N/A
- BANX 2.35
- Revenue
- SGMO $81,706,000.00
- BANX $29,467,794.00
- Revenue This Year
- SGMO $28.47
- BANX N/A
- Revenue Next Year
- SGMO N/A
- BANX N/A
- P/E Ratio
- SGMO N/A
- BANX $8.88
- Revenue Growth
- SGMO 565.52
- BANX 2.73
- 52 Week Low
- SGMO $0.41
- BANX $17.99
- 52 Week High
- SGMO $3.18
- BANX $21.67
- Technical
- Relative Strength Index (RSI)
- SGMO 66.82
- BANX 57.78
- Support Level
- SGMO $0.65
- BANX $22.00
- Resistance Level
- SGMO $0.73
- BANX $22.16
- Average True Range (ATR)
- SGMO 0.06
- BANX 0.49
- MACD
- SGMO 0.02
- BANX -0.04
- Stochastic Oscillator
- SGMO 67.74
- BANX 22.58
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.